Oslo Universitetssykehus Ullevål

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Ulcerative colitis2 trials
• Aortic stenosis1 trial
• Crohn's disease1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Not yet recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Helse Møre og Romsdal HF1 trial
• Medtronic Cardiovascular1 trial
• Novo Nordisk A/S1 trial

Running trials

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

  Contact: Haavard Midgard (principal investigator)

• Recruiting

  A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  NCT04844606· Phase 3· Eli Lilly and Company· Source

  Contact: Gori Perminow (principal investigator)

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Novo Nordisk A/S· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System

  NCT03417011· Medtronic Cardiovascular· Source

• Completed

  Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?

  NCT03011268· Helse Møre og Romsdal HF· Source